Compare ADMA Biologics Inc (ADMA) vs EPAM Systems Inc (EPAM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs EPAM Systems Inc — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while EPAM Systems Inc trades at $99.3 (market cap $5.15B). The key difference: EPAM Systems Inc is far larger — about 2.3× ADMA Biologics Inc's market cap. Which is the better fit depends on your goals.
| ADMA | EPAM | |
|---|---|---|
Market Cap | $2.22B | $5.15B |
Sector | Health | Technology |
52-Week High | $20.38 | $221.40 |
52-Week Low | $7.60 | $76.04 |
Enterprise Value | $2.29B | $4.52B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About EPAM Systems Inc
EPAM Systems Inc provides software product development and digital platform engineering services to clients located around the world. The company services include Software Product Development, Custom Application Development, Application Testing, Enterprise Application Platforms, Application Maintenance, and Support and Infrastructure Management. The company focuses on innovative and scalable software solutions. The company uses industry standard and custom developed technology, tools, and platforms to deliver results to handle business challenges. The company primarily offers its solutions in the following industries: financial services, travel and consumer, software and hi-tech, life sciences and healthcare. The majority of revenue is generated from North American clients.
Read more on EPAM →
